Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Jin Yang Pharmaceutical Co., Ltd. (007370)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
4,015.
00
+35
+0.8794%
₩
51.52B
Market Cap
-
P/E Ratio
600%
Div Yield
26,116
Volume
-
Eps
₩
3,980
Previous Close
Watching
Watch
Add Transaction
Day Range
3,945
4,020
Year Range
3,350
6,110
Want to track
007370
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Jin Yang Pharmaceutical Co., Ltd. (007370) Statistics
Valuation metrics
Market Cap
51.52B
Enterprise value
123.91B
Trailing P/E (ttm)
2.28
Forward P/E
-
PEG ratio
-0.13
Price/Sales (ttm)
0.42
Price/Book (mrq)
0.37
Enterprise Value/Revenue
1.01
Enterprise Value/EBITDA
27.59
Overview
Shares outstanding
12.35M
Float
8.97M
Shares short
-
% Held by insiders
0.4%
% Held by institutions
-
Average volume (10 days)
41.3K
Average volume (90 days)
38.78K
Price summary
52-Week low
3,350
52-Week high
6,110
Beta
0.3
50-Day moving average
4,618.3
200-Day moving average
5,113.1
Dividends and splits
Forward annual dividend rate
600
Forward annual dividend yield
0.1439%
Trailing annual dividend rate
150
Trailing annual dividend yield
0.036%
5-Year annual dividend yield
2.29%
Payout ratio
0.08
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
1:10
Last split Date
25 Apr 2005
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.18%
Operating margin
0.1%
Operational effectiveness
Return on assets
0.01%
Return on equity
0.16%
Income Statement
Revenue (ttm)
122.15B
Revenue per share (ttm)
9,900.15
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
80.11B
EBITDA
33.14B
Net income to common (ttm)
22.29B
Diluted EPS (ttm)
1,808
Quarterly earnings growth (yoy)
0%
Balance Sheet
Total cash (mrq)
6.06B
Total cash per share (mrq)
471.51
Total debt (mrq)
76.37B
Total Debt/Equity (mrq)
47.74
Current ratio (mrq)
0.52%
Book value per share (mrq)
11,284.79
Cash Flow
Cash flow statement
3.36B
Levered free cash flow (LFCF)
-4.72B